The long-term efficacy and tolerability of hyaluronic acid in adult patients with Kashin–Beck disease of the knee
详细信息 查看全文
- 作者：Xin Tang ; Zong-Ke Zhou ; Gang Liu ; Bin Shen ; Peng-De Kang ; Jian Li…
- 关键词：Efficacy ; Hyaluronic acid ; Kashin–Beck disease ; Knee
- 刊名：Clinical Rheumatology
- 出版年：2015
- 出版时间：January 2015
- 年：2015
- 卷：34
- 期：1
- 页码：151-156
- 全文大小：153 KB
- 参考文献：1. Sokoloff L (1989) The history of Kashin–Beck disease. N Y State J Med 89:343-51
2. Chinese Health Statistical Digest (2010) http://www.moh.gov.cn/publicfiles/business/htmlfiles/zwgkzt/ptjty/digest2010/index.html
3. Schepman K, Engelbert RH, Visser MM, Yu C, de Vos R (2011) Kashin Beck disease: more than just osteoarthrosis: a cross-sectional study regarding the influence of body function-structures and activities on level of participation. Int Orthop 35:767-76 CrossRef
4. Guo X (2001) Diagnostic, clinical and radiological characteristics of Kashin Beck disease in Shaanxi Province, PR China. Int Orthop 25:147-50 CrossRef
5. Li Y, Zhou Z, Shen B, Yang J, Kang P, Yang X et al (2013) Clinical features of Kashin–Beck disease in adults younger than 50?years of age during a low incidence period: severe elbow and knee lesions. Int Orthop 32:317-24
6. Zhou Z, Shen B, Pei F, Kang P, Li J, Yang J et al (2009) Relation between affected big joints and classification of Kashin–Beck disease in adult of Tibet. Chin J Bone Joint Surg 2:352-56
7. Cao J, Li S, Shi Z, Yue Y, Sun J, Chen J et al (2008) Articular cartilage metabolism in patients with Kashin–Beck disease: an endemic osteoarthropathy in China. Osteoarthr Cartil 16:680-88 CrossRef
8. Bannuru RR, Natov NS, Dasi UR, Schmid CH, McAlindon TE (2011) Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis—meta-analysis. Osteoarthr Cartil 19:611-19 CrossRef
9. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM (2004) Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 86-A:538-45
10. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 19, CD005321
11. Xu P, Guo X, Jin W, Yao J, Wang J, Zhang F et al (2004) Curative effects of intra-articular injections of sodium hyaluronate to treat Kashin–Beck disease. Chin J Endemiol 23:588-90
12. Tang X, Pei FX, Zhou ZK, Liu G, Shen B, Kang PD et al (2012) A randomized, single-blind comparison of the efficacy and tolerability of hyaluronate acid and meloxicam in adult patients with Kashin–Beck disease of the knee. Clin Rheumatol 31:1079-086 CrossRef
13. Li F, Deng J, Zhou D, Yang R, Li D, Ma G et al (2005) Analysis on monitoring data of Kashin–Beck disease in Sichuan Province in 2005. J Prev Med Inf 21:666-68
14. Mathieu F, Begaux F, Lan ZY, Suetens C, Hinsenkamp M (1997) Clinical manifestations of Kashin–Beck disease in Nyemo Valley, Tibet. Int Orthop 21:151-56 CrossRef
15. Kellgren JH, Lawrence JS (1957) Radiographic assessment of osteoarthritis. Ann Rheum Dis 16:494-02 CrossRef
16. Bellamy N (1995) WOMAC osteoarthritis index—a user’s guide. Canada, London Health Sciences Centre, London
17. Bellamy N (2002) WOMAC: a 20-year experiential review of a patient-centered self-reported health status questionnaire. J Rheumatol 29:2473-476
18. Theiler R, Brühlmann P (2005) Overall tolerability and analgesic activity of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Curr Med Res Opin 21:1727-733 CrossRef
19. Conrozier T, Mathieu P, Schott AM, Laurent I, Hajri T, Crozes P et al (2003) Factors predicting long-term efficacy of Hylan GF-20 viscosupplementation in knee osteoarthritis. Joint Bone Spine 70:128-33 CrossRef
20. Jüni P, Reichenbach S, Trelle S, Tschannen B, Wandel S, Jordi B et al (2007) Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial. Arthritis Rheum 56:3610-619
文摘
The aim of this study was to prospectively evaluate the long-term efficacy and tolerability of hyaluronic acid (HA) for the treatment of knee pain due to Kashin–Beck disease (KBD). A total of 113 patients with KBD-based knee pain were treated with a 3-week course of HA. Clinical assessments were performed for each patient at 0 (baseline), 1, 2, 4, 8, 12, 24, and 52?weeks. The primary efficacy measure was the visual analog scale (VAS) pain score. The secondary efficacy measures included the WOMAC A (pain), B (stiffness), and C (function) scores; the total WOMAC score; and the global assessments by patients and physicians. Tolerability was evaluated based on adverse events (AEs) and physician reporting. The VAS was significantly reduced within the first 4?weeks of treatment, and the reduction was maintained over 52?weeks (p--.001 at each endpoint). These data were supported by the secondary variables WOMAC A (all p--.001), WOMAC B (p--.002, 0.003, and 0.019, respectively), WOMAC C (all p--.001), total WOMAC (all p--.001), and the global assessments by patients and physicians at weeks 12, 24, and 52. No serious AEs were reported, and the overall incidence of AEs was 10.6?%. This study suggests that the intra-articular injection of HA is effective and well tolerated for the treatment of knee pain due to KBD as HA therapy resulted in an improvement of symptoms for at least 52?weeks. Additional randomized double-blind studies are needed to confirm our findings.